---

title: Hyperkalemia
authors:
    - Michelle Lin, MD
created: 2010/03/12
updates:
categories:
    - Endocrinology
    - Metabolic
    - Critical Care
---

# Hyperkalemia

## Potassium regulation

- **Internal K shift:** modulated by insulin, catecholamines, acid-base status
- **Total body K elimination:** By kidney (95%) and gut (5%)

## Adverse effects of hyperkalemia

- **Cardiac:** Peaked T, wide QRS, loss of P wave, sine wave; although ventricular fibrillation may be first cardiac manifestation
- **Neuromuscular:** Paresthesias,weakness
- **Metabolic:** Mild hyperchloremic metabolic acidosis

## Treatment of hyperkalemia

**Mechanism: Cardiac membrane stabilization**

- **Calcium:** Reduces threshold potential in myocytes; check to be sure not on digoxin
- **Hypertonic saline:** Only for severe hyponatremia in setting of hyperkalemia

**Mechanism: K redistribution**

- **Insulin:** Drives K intracellularly and drops serum K level by 0.6 mmol/L
- **Beta-agonist:** Drives K intracellularly and 10 mg albuterol drops serum K level by 0.6 mmol/L (20 mg --> K drops by 1 mmol/L); effective in only 60% of patients

**Mechanism: K elimination via kidney/gut**

- **Bicarbonate:** drives K out at distal nephron; best as infusion x 4-6 hrs
- **Loop diuretic**
- **Exchange resin** (sodium polystyrene sulfonate): Of minimal to no benefit. 
  - Case reports of colonic necrosis 

<table>
  <tr>
    <th>Agent</th>
    <th>Dose</th>
    <th>Onset</th>
    <th>Duration</th>
    <th>Complication</th>
  </tr>
  <tr>
    <td colspan="5"><b>MEMBRANE STABILIZATION</b></td>
  </tr>
  <tr>
    <td><span class="drug">Ca gluconate 10%</span></td>
    <td>10 mL over 10 min</td>
    <td>Immediate</td>
    <td>30-60 min</td>
    <td>Hypercalcemia</td>
  </tr>
  <tr>
    <td><span class="drug">Hypertonic 3% NaCl</span></td>
    <td>50 mL IV push</td>
    <td>Immediate</td>
    <td>Unknown</td>
    <td>Volume overload, hypertonicity</td>
  </tr>
  <tr>
  <td colspan="5"><b>REDISTRIBUTION</b></td>
  </tr>
  <tr>
    <td><span class="drug">Insulin</span></td>
    <td>10 units IVP with D50W</td>
    <td>20 min</td>
    <td>4-6 hr</td>
    <td>Hypoglycemia</td>
  </tr>
  <tr>
    <td><span class="drug">Albuterol nebulized</span></td>
    <td>20 mg/4 cc over 10 min</td>
    <td>30 min</td>
    <td>2 hrs</td>
    <td>Tachycardia</td>
  </tr>
  <tr>
  <td colspan="5"><b>ELIMINATION</b></td>
  </tr>
  <tr>
    <td><span class="drug">Loop diuretic</span></td>
    <td>Furosemide 40-80 mg IV</td>
    <td>15 min</td>
    <td>2-3 hr</td>
    <td>Volume depletion</td>
  </tr>
  <tr>
    <td><span class="drug">Sodium bicarbonate</span></td>
    <td>150 mmol/L IV</td>
    <td>Hours</td>
    <td>Infusion</td>
    <td>Metabolic alkalosis, volume overload</td>
  </tr>
  <tr>
    <td><span class="drug">Kayexalate</span></td>
    <td>15-30 g</td>
    <td>>2 hrs</td>
    <td>4-6 hr</td>
    <td>Variable efficacy</td>
  </tr>
  <tr>
    <td><span class="drug">Hemodialysis</span></td>
    <td></td>
    <td>Immediate</td>
    <td>3 hrs</td>
    <td>Arrhythmias</td>
  </tr>
</table>

## References

- Weisberg LS. Management of severe hyperkalemia. _Crit Care Med_. 2008; 36:3246-51. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=18936701)]
